What is the treatment for convulsions (seizures) in a patient with malaria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Convulsions in Malaria

For convulsions in patients with malaria, administer paraldehyde 0.2 mL/kg IM for initial seizure control, followed by phenobarbital 10 mg/kg IM if convulsions persist. 1

Initial Management of Seizures in Malaria

Emergency Assessment

  1. Position patient in left lateral position
  2. Check blood glucose immediately (hypoglycemia may precipitate seizures) 1
  3. Ensure adequate airway management and provide oxygen if hypoxic 1
  4. Monitor for subtle seizures (eye deviation, irregular respiratory pattern, drooling) 1

First-Line Anticonvulsant Therapy

  • For initial convulsion:

    • Administer paraldehyde 0.2 mL/kg IM 1
    • If convulsions recur, repeat the paraldehyde dose 1
  • For persistent convulsions:

    • Administer phenobarbital 10 mg/kg IM 1
    • Alternative in hospital setting: Follow APLS seizure management algorithm with lorazepam 0.1 mg/kg IV/IO 1

Comprehensive Management Approach

Diagnostic Considerations

  • In children with altered consciousness or repeated convulsions:
    • Perform lumbar puncture if possible to rule out meningitis 1
    • If CSF is cloudy, treat for meningitis and discontinue antimalarial treatment 1
    • If lumbar puncture cannot be performed, treat for both meningitis and malaria 1

Antimalarial Treatment

  • If patient can swallow:

    • Administer appropriate oral antimalarial (sulfadoxine-pyrimethamine or artemisinin-based combination) 1, 2
  • If patient cannot swallow or has persistent vomiting:

    • Administer IV quinine: Loading dose 20 mg/kg over 4 hours, then 10 mg/kg every 8-12 hours 1
    • For severe malaria: IV artesunate is now first-line therapy (20 mg/kg) 2, 3

Management of Complications

  • Hypoglycemia prevention and treatment:

    • Use 5% dextrose with 1/2 normal saline for IV fluids 1
    • For confirmed hypoglycemia: Administer 50 mL of 50% IV dextrose 1
  • Fluid management:

    • Exercise caution with fluid administration to prevent pulmonary edema and cerebral edema 1
    • Maintain cardiac output and renal perfusion while avoiding fluid overload 1

Special Considerations

Seizure Prophylaxis

  • Prophylactic anticonvulsants are generally not recommended in modern settings 1
  • However, a single dose of phenobarbital (3.5 mg/kg IM) has been shown to reduce subsequent convulsions from 54% to 12.5% in cerebral malaria 4

Route of Administration

  • IV administration of anticonvulsants provides more reliable plasma concentrations than rectal administration 5
  • If IV access is unavailable, rectal diazepam (0.5 mg/kg) can be used, though it has more variable absorption 5

Monitoring

  • Close monitoring for recurrent seizures is essential as many patients (especially with IV diazepam) may experience seizure recurrence 5
  • Monitor for signs of raised intracranial pressure, which may complicate cerebral malaria 1

Pitfalls to Avoid

  1. Failing to recognize subtle seizures that present as eye deviation or irregular breathing patterns 1, 6
  2. Delaying treatment of convulsions lasting more than 5 minutes (associated with neurological deficits) 6
  3. Overlooking hypoglycemia as a cause or complication of seizures 1
  4. Using mefloquine in patients with seizures (may lower seizure threshold) 7
  5. Administering steroids (adverse effect on outcome in cerebral malaria) 1

Remember that severe malaria with convulsions is a medical emergency requiring prompt intervention to reduce morbidity and mortality.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.